Treatment with IL30 also upregulated tumor progression genes, such as Ar (3.27 times), Bcl2 (3.25 times), IL6 (3.90 times), Cav2 (7.60 times), Ndrg3 (4.5 times), Sept7 (4.10 times) and Sfrp1 (7.46 times) (Fig. 2A). Here, NDRG3 is linked to neoplasm.